Data science tools and applications on the way to Pharma 4.0
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles in the biopharma life cycle. Pharma 4.0 concepts, such as cyberphysical systems and dark factories, require data science tools as technological core components. Here, we review current data science applications at various stages of the bioprocess life cycle, including their scopes and data sources. We are convinced that the scope and usefulness of these tools are currently limited by technical and nontechnical problems experienced during their development and deployment. We suggest that the establishment of development opportunity mind- and toolsets could improve this situation and would be essential cornerstones in the further development of Pharma 4.0 systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Data-driven Soft Sensors in the process industry
Kadlec, P., Gabrys, B., & Strandt, S. (2009) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2008.12.012 · Cited by 1,845
Key cost drivers of pharmaceutical clinical trials in the United States
Sertkaya, A., Wong, H.-H., Jessup, A., & Beleche, T. (2016) · Clinical Trials · doi:10.1177/1740774515625964 · Cited by 401
Drugs, Devices, and the FDA: Part 1
Van Norman, G. A. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.002 · Cited by 366
Bioreactor monitoring with spectroscopy and chemometrics: a review
Lourenço, N. D., Lopes, J. A., Almeida, C. F., Sarraguça, M. C., & Pinheiro, H. M. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6073-9 · Cited by 275
Wechselberger, P., Sagmeister, P., & Herwig, C. (2013) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-012-0848-4 · Cited by 102
Self-citation
Cited by
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachandran, R., & Ierapetritou, M. (2020) · Processes · doi:10.3390/pr8091088 · Cited by 278
Wasalathanthri, D. P., Rehmann, M. S., Song, Y., Gu, Y., Mi, L., Shao, C., Chemmalil, L., Lee, J., Ghose, S., Borys, M. C., et al. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27461 · Cited by 177
Bioprocess Control: Current Progress and Future Perspectives
Rathore, A. S., Mishra, S., Nikita, S., & Priyanka, P. (2021) · Life · doi:10.3390/life11060557 · Cited by 141
Rolinger, L., Rüdt, M., & Hubbuch, J. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02407-z · Cited by 126
Metadata
- Authors
- Steinwandter, V., Borchert, D., & Herwig, C.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 24
- Issue
- 9
- Pages
- 1795-1805
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2953260158
- Cited by
- 156
- References
- 6
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Data science tools and applications on the way to Pharma 4.0. https://app.cochat.ai/papers/10.1016/j.drudis.2019.06.005
- The paper
- Steinwandter, V., Borchert, D., & Herwig, C. (2019). Data science tools and applications on the way to Pharma 4.0. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2019.06.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.